Learn about the emerging companies, finance trends, and strategic drivers impacting the global medtech industry.
Field Medical is developing a next-generation pulsed field ablation (PFA) solution for the treatment of cardiac arrhythmia.
NEXT Life Sciences is a medical device company that plans to deliver a non-hormonal, long lasting, and reversible male contraceptive solution empowering men and their partners to choose if and when to have a child.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability.
Fusion Fund backs early-stage startups that leverage technical or data advantages.
Avail Medsystems is a pioneering medical technology company that provides simple cost-effective solutions that connect procedural healthcare professionals regardless of location.
Priveterra Capital is focused on disruptive opportunities in LifeSciences.
Founded in 2012, PRIA Healthcare is the industry-leading strategic reimbursement, market, and patient access partner for medical device companies in the United States.
Nephrodite is developing and commercializing a fully implantable continuous dialysis device - The Holly.
Medinbox has developed a real-time, smart collaboration solution for use in the operating room and cathlab.
"The Rise of Health System Investors and Corporate Venture Capitalist" explores the increasing trend of healthcare organizations and corporate investors investing in healthcare startups and innovative technologies.
The panelist dive deep into the challenges of monetizing the vast amounts of data generated by medical technology and explores potential solutions and opportunities for innovation.
The panelist provide a critical assessment of the current and potential applications of augmented and virtual reality technologies in the fields of healthcare and medicine.
This panel explores the perspectives and experiences of emerging leaders in the Medtech industry, highlighting their innovative approaches to addressing key challenges in healthcare.
This discussion explores the operational and R&D implications of Medtech M&A throughout the pre-deal, due diligence, and post-closure phases.
A conversation focusing on the progress made towards developing a medical device that can modify the progression of Alzheimer's disease.
"Healthcare Marketing in the Digital Creator Age" explores how the healthcare industry can leverage digital marketing strategies to effectively reach and engage their potential audience.
Elisabeth Staudinger joined Siemens in 1998 and has worked in international management roles spanning from procurement and strategy, to marketing, manufacturing, and business unit CEO, in both Germany and Asia Pacific.
This panel provides insightful perspectives and valuable lessons learned two professionals who have transitioned from positions in start-ups to the investment side, and vice versa.
Darwin Shurig presents Shurig Solution's and the importance of hiring the right people that fit your mission and culture.
Experienced professionals provide insights on how to generate value for stakeholders in the medical technology industry throughout the investment and exit processes.
Industry leaders exploring individual company strategies and insights in the ever-evolving field of global medtech.
This discussion emphasizes the critical importance of real-time assessment and monitoring in the diagnosis and treatment of stroke and traumatic brain injuries to stop or prevent further damage.
This discussion will analyze a one case study of a successful medtech deal where each panelist is from a different side of this one deal.
This panel highlights two founders with unique paths, and the latest updates with their companies.
An insightful discussion about how the utilization of various emerging technological advancements is going to assist and enhance the abilities of surgeons before, during, and after a surgical procedure.
This discussion will explore how the influx of recent data has influenced the latest advancements in medtech innovation for software, diagnostics, and imaging.
A discussion about the role of clinicians in driving innovation and investment in the medtech industry, highlighting the benefits of their unique perspective and expertise.
An up-to-date perspective between investors focusing on the opportunities and challenges of investing in a growth stage healthcare or medtech start-up, while exploring the factors that can drive success in these industries.
In this discussion, experts examine the changing landscape of Medtech investment and the emerging players who are driving the growth and evolution of this rapidly evolving industry
This discussion focuses on the perspectives of different investors in regards to the similarities and differences between healthtech, medtech, and biotech, and how to identify promising investment opportunities in each category.
